Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SALETU B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 94 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rappelsberger, P; Trenker, E; Rothmann, C; Gruber, G; Sykacek, P; Roberts, S; Klosch, G; Zeitlhofer, J; Anderer, P; Saletu, B; Schlogl, A; Varri, A; Kemp, B; Penzel, T; Herrmann, W; Hasan, J; Barbanoj, MJ; Kunz, D; Dorffner, G
      The SIESTA project

      KLINISCHE NEUROPHYSIOLOGIE
    2. Saletu, M; Anderer, P; Saletu-Zyhlarz, G; Prause, W; Semler, B; Zoghlami, A; Gruber, G; Hauer, C; Saletu, B
      Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) - Acute placebo-controlled sleep laboratory studies with clonazepam

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    3. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Semler, B; Saletu-Zyhlarz, G
      Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    4. Klosch, G; Kemp, B; Penzel, T; Schlogl, A; Rappelsberger, P; Trenker, E; Gruber, G; Zeitlhofer, J; Saletu, B; Herrmann, WM; Himanen, SL; Kunz, D; Barbanoj, MJ; Roschke, J; Varri, A; Dorffner, G
      The SIESTA project polygraphic and clinical database

      IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE
    5. Anderer, P; Klosch, G; Gruber, G; Trenker, E; Pascual-Marqui, RD; Zeitlhofer, J; Barbanoj, MJ; Rappelsberger, P; Saletu, B
      Low-resolution brain electromagnetic tomography revealed simultaneously active frontal and parietal sleep spindle sources in the human cortex

      NEUROSCIENCE
    6. Saletu-Zyhlarz, GM; Abu-Bakr, MH; Anderer, P; Semler, B; Decker, K; Parapatics, S; Tschida, U; Winkler, A; Saletu, B
      Insomnia related to dysthymia: Polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone

      NEUROPSYCHOBIOLOGY
    7. Fruhwald, S; Loffler, H; Eher, R; Saletu, B; Baumhackl, U
      Relationship between depression, anxiety and quality of life: A study of stroke patients compared to chronic low back pain and myocardial ischemia patients

      PSYCHOPATHOLOGY
    8. Mayerhofer, K; Bodner, K; Saletu, B; Bodner-Adler, B; Anderer, P; Hefler, L; Schindl, M; Kaider, A; Leodolter, S; Kainz, C
      Paclitaxel-carboplatin chemotherapy does not cause encephalopathy in patients with ovarian cancer: A prospective EEG mapping study in 28 patients

      ANTICANCER RESEARCH
    9. Fruhwald, S; Loffler-Stastka, H; Eher, R; Saletu, B; Baumhackl, U
      The relationship between symptoms of depression and anxiety and quality oflife in multiple sclerosis

      WIENER KLINISCHE WOCHENSCHRIFT
    10. Ipsiroglu, OS; Saletu, B
      Sleep medicine from the scientific to the routine - How long should we look the other way?

      WIENER KLINISCHE WOCHENSCHRIFT
    11. Frey, R; Klosch, G; Reinfried, L; Decker, K; Saletu, B; Laggner, AN
      Physicians' tiredness and perception of stress after a 16-hour working period at the emergency department

      WIENER KLINISCHE WOCHENSCHRIFT
    12. Saletu, B; Anderer, P; Saletu-Zyhlarz, GM
      Nonorganic hypersomnia - Epidemiology, diagnosis and treatment

      WIENER KLINISCHE WOCHENSCHRIFT
    13. Klosch, G; Gruber, G; Anderer, P; Saletu, B
      Activity monitoring in sleep research, medicine and psychopharmacology

      WIENER KLINISCHE WOCHENSCHRIFT
    14. Happe, S; Klosch, G; Saletu, B; Zeitlhofer, J
      Treatment of idiopathic restless legs syndrome (RLS) with gabapentin

      NEUROLOGY
    15. Saletu, B; Anderer, P; Gruber, G; Mandl, M; Gruber, D; Metka, M; Huber, J; Loffler, H; Abu-Bakr, MH; Saletu-Zyhlarz, GM
      Insomnia related to postmenopausal syndrome: Sleep laboratory studies on differences between patients and normal controls, and influence of an estrogen-progestogen combination with dienogest versus estrogen alone and placebo

      DRUGS OF TODAY
    16. Linzmayer, L; Semlitsch, HV; Saletu, B; Bock, G; Saletu-Zyhlarz, G; Zoghlami, A; Gruber, D; Metka, M; Huber, J; Oettel, M; Graser, T; Grunberger, J
      Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    17. Fruehwald, S; Loeffler-Stastka, H; Eher, R; Saletu, B; Baumhackl, U
      Depression and quality of life in multiple sclerosis

      ACTA NEUROLOGICA SCANDINAVICA
    18. Anderer, P; Saletu, B; Pascual-Marqui, RD
      Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA)

      PSYCHIATRY RESEARCH-NEUROIMAGING
    19. Saletu-Zyhlarz, GM; Anderer, PA; Berger, P; Gruber, G; Oberndorfer, S; Saletu, B
      Nonorganic insomnia in panic disorder: Comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    20. Oberndorfer, S; Saletu, B; Gruber, G; Anderer, P; Saletu, M; Mandl, M; Saletu-Zyhlarz, G
      Theophylline in snoring and sleep-related breathing disorders: Sleep laboratory investigations on subjective and objective sleep and awakening quality

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    21. Howorka, K; Pumprla, J; Saletu, B; Anderer, P; Krieger, M; Schabmann, A
      Decrease of vigilance assessed by EEG-mapping in Type I diabetic patients with history of recurrent severe hypoglycaemia

      PSYCHONEUROENDOCRINOLOGY
    22. Brunello, N; Armitage, R; Feinberg, I; Holsboer-Trachsler, E; Leger, D; Linkowski, P; Mendelson, WB; Racagni, G; Saletu, B; Sharpley, AL; Turek, F; Van Cauter, E; Mendlewicz, J
      Depression and sleep disorders: Clinical relevance, economic burden and pharmacological treatment

      NEUROPSYCHOBIOLOGY
    23. Oberndorfer, S; Saletu-Zyhlarz, G; Saletu, B
      Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality

      NEUROPSYCHOBIOLOGY
    24. Saletu, B; Gruber, G; Saletu, M; Brandstatter, N; Hauer, C; Prause, W; Ritter, K; Saletu-Zyhlarz, G
      Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole 1. Findings on objective and subjective sleep and awakening quality

      NEUROPSYCHOBIOLOGY
    25. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Oberndorfer, S; Zoghlami, A; Saletu-Zyhlarz, G
      Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole 2. Findings on periodic leg movement, arousals and respiratory variables

      NEUROPSYCHOBIOLOGY
    26. Saletu-Zyhlarz, G; Anderer, P; Brandstatter, N; Dantendorfer, K; Gruber, G; Mandl, M; Ritter, K; Zoghlami, A; Saletu, B
      Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder

      NEUROPSYCHOBIOLOGY
    27. Mayerhofer, K; Bodner-Adler, B; Bodner, K; Saletu, B; Schindl, M; Kaider, A; Hefler, L; Leodolter, S; Kainz, C
      A paclitaxel-containing chemotherapy does not cause central nervous adverse effects: A prospective study in patients with ovarian cancer

      ANTICANCER RESEARCH
    28. Saletu, M; Hauer, C; Anderer, P; Saletu-Zyhlarz, G; Gruber, G; Oberndorfer, S; Mandl, M; Popovic, R; Saletu, B
      Daytime tiredness correlates with nocturnal respiratory and arousal variables in sleep apnea patients: Polysomnography and EEG mapping investigations

      WIENER KLINISCHE WOCHENSCHRIFT
    29. Mayerhofer, K; Bodner, K; Saletu, B; Bodner-Adler, B; Anderer, P; Hefler, L; Kaider, A; Leodolter, S; Kainz, C
      Paclitaxel does not cause central nervous adverse effects: A prospective vigilance-controlled EEG mapping study in ovarian cancer patients

      WIENER KLINISCHE WOCHENSCHRIFT
    30. Zeitlhofer, J; Schmeiser-Rieder, A; Tribl, G; Rosenberger, A; Bolitschek, J; Kapfhammer, G; Saletu, B; Katschnig, H; Holzinger, B; Popovic, R; Kunze, M
      Sleep and quality of life in the Austrian population

      ACTA NEUROLOGICA SCANDINAVICA
    31. Anderer, P; Roberts, S; Schlogl, A; Gruber, G; Klosch, G; Herrmann, W; Rappelsberger, P; Filz, O; Barbanoj, MJ; Dorffner, G; Saletu, B
      Artifact processing in computerized analysis of sleep EEG - A review

      NEUROPSYCHOBIOLOGY
    32. Saletu, B; Oberndorfer, S; Anderer, P; Gruber, G; Divos, H; Lachner, A; Mandl, M; Parapatics, S; Popp, W; Salet, M; Saletu-Zyhlarz, G; Sertl, K; Strobl, R; Tschida, U; Winkler, A
      Efficiency of continuous positive airway pressure versus theophylline therapy in sleep apnea: Comparative sleep laboratory studies on objective and subjective sleep and awakening quality

      NEUROPSYCHOBIOLOGY
    33. STEPANSKY R; HOLZINGER B; SCHMEISERRIEDER A; SALETU B; KUNZE M; ZEITLHOFER J
      AUSTRIAN DREAM BEHAVIOR - RESULTS OF A REPRESENTATIVE POPULATION SURVEY

      Dreaming
    34. ANDERER P; PASCUALMARQUI RD; SEMLITSCH HV; SALETU B
      ELECTRICAL SOURCES OF P300 EVENT-RELATED BRAIN POTENTIALS REVEALED BYLOW-RESOLUTION ELECTROMAGNETIC TOMOGRAPHY .1. EFFECTS OF NORMAL AGING

      Neuropsychobiology
    35. ANDERER P; SALETU B; SEMLITSCH HV; PASCUALMARQUI RD
      ELECTRICAL SOURCES OF P300 EVENT-RELATED BRAIN POTENTIALS REVEALED BYLOW-RESOLUTION ELECTROMAGNETIC TOMOGRAPHY .2. EFFECTS OF NOOTROPIC THERAPY IN AGE-ASSOCIATED MEMORY IMPAIRMENT

      Neuropsychobiology
    36. ANDERER P; PASCUALMARQUI RD; SEMLITSCH HV; SALETU B
      DIFFERENTIAL-EFFECTS OF NORMAL AGING ON SOURCES OF STANDARD N1, TARGET N1 AND TARGET P300 AUDITORY EVENT-RELATED BRAIN POTENTIALS REVEALED BY LOW-RESOLUTION ELECTROMAGNETIC TOMOGRAPHY (LORETA)

      Electroencephalography and clinical neurophysiology. Evoked potentials
    37. HOWORKA K; PUMPRLA J; ANDERER P; SALETU B; SCHABMANN A
      EEG-MAPPING - DECREASE OF VIGILANCE IN TYPE-1 DIABETIC-PATIENTS WITH HISTORY OF REPEATED SEVERE HYPOGLYCEMIA

      Diabetologia
    38. PUMPRLA J; HOWORKA K; ANDERER P; SALETU B; KRIEGER M; SCHABMANN A
      REDUCTION OF LOW-FREQUENCY BAND SPECTRAL POWER AND CENTROID FREQUENCYIN ANALYSIS OF HEART-RATE-VARIABILITY IN DIABETIC-PATIENTS WITH HYPOGLYCEMIA UNAWARENESS

      Diabetologia
    39. LOFFLER H; SALETU B; GRUBER D; LINZMAYER L; MANDL M; METKA M; HUBER J; ANDERER P
      QUALITY-OF-LIFE IN INSOMNIACS WITH A POSTMENOPAUSAL SYNDROME

      Quality of life research
    40. SALETU B; LOFFLER H; ANDERER P; DECKER K; GRUBER G; KLOSCH G; KIRCHEIS L; MANDL M; PARAPATICS S; TSCHIDA U; KATSCHNIG H
      QUALITY-OF-LIFE IN NONORGANIC AND ORGANIC SLEEP DISORDERS

      Quality of life research
    41. ZEITLHOFER J; GRUBER G; ANDERER P; ASENBAUM S; SCHIMICEK P; SALETU B
      TOPOGRAPHIC DISTRIBUTION OF SLEEP SPINDLES IN YOUNG HEALTHY-SUBJECTS

      Journal of sleep research
    42. GRUNBERGER J; SALETU B; LINZMAYER L; BOCK G; WEISSGRAM S; BRANDSTAATTER N; FREY R; SALETUZYHLARZ G
      COMPARATIVE-STUDIES ON THE EFFECTS OF THE COMBINATION-DRUG LORAZEPAM PLUS DIPHENHYDRAMINE (SOMNIUM(R)) VERSUS LORAZEPAM ON THE NOOPSYCHE, THYMOPSYCHE AND PSYCHOPHYSIOLOGY IN NONORGANIC INSOMNIA RELATED TO GENERALIZED ANXIETY DISORDER

      Methods and findings in experimental and clinical pharmacology
    43. SALETUZYHLARZ G; SALETU B; ANDERER P; BRANDSTATTER N; FREY R; GRUBER G; KLOSCH G; MANDL M; GRUNBERGER J; LINZMAYER L
      NONORGANIC INSOMNIA IN GENERALIZED ANXIETY DISORDER .1. CONTROLLED-STUDIES ON SLEEP, AWAKENING AND DAYTIME VIGILANCE UTILIZING POLYSOMNOGRAPHY AND EEG MAPPING

      Neuropsychobiology
    44. SALETU B; SALETUZYHLARZ G; ANDERER P; BRANDSTATTER N; FREY R; GRUBER G; KLOSCH G; MANDL M; GRUNBERGER J; LINZMAYER L
      NONORGANIC INSOMNIA IN GENERALIZED ANXIETY DISORDER .2. COMPARATIVE-STUDIES ON SLEEP, AWAKENING, DAYTIME VIGILANCE AND ANXIETY UNDER LORAZEPAM PLUS DIPHENHYDRAMINE (SOMNIUM(R)) VERSUS LORAZEPAM ALONE, UTILIZING CLINICAL, POLYSOMNOGRAPHIC AND EEG MAPPING METHODS

      Neuropsychobiology
    45. SCHMITZ M; FREY R; PICHLER P; ROPKE H; ANDERER P; SALETU B; RUDAS S
      SLEEP QUALITY DURING ALCOHOL-WITHDRAWAL WITH BRIGHT LIGHT THERAPY

      Progress in neuro-psychopharmacology & biological psychiatry
    46. STEPANSKY R; ASENBAUM S; SALETU B; ZEITLHOFER J
      NEUROLOGICAL SLEEP DISTURBANCES - HYPERSO MNIAS

      Wiener Klinische Wochenschrift
    47. SALETU B
      MELATONIN - A NATURAL SLEEPING-PILL

      Wiener Klinische Wochenschrift
    48. SALETU B
      SLEEP DISORDERS - IDIOPATHIC DISEASES, SY MPTOMS OR PERFORMANCE OF SPECIALISTS

      Wiener Klinische Wochenschrift
    49. SALETU B; BRANDSTATTER N; FREY R; SALETUZYHLARZ GM; DANTENDORFER K; BERGER P; LOFFLER H
      CLINICAL-EVALUATION OF SLEEP DISORDERS - AN ANALYSIS OF 817 PATIENTS ATTENDING A SLEEPOUT-PATIENT CLINIC

      Wiener Klinische Wochenschrift
    50. SALETU B; ANDERER P; SEMLITSCH HV
      RELATIONS BETWEEN SYMPTOMATOLOGY AND BRAIN-FUNCTION IN DEMENTIAS - DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL AND EEG ERP MAPPING STUDIES WITH NICERGOLINE/

      Dementia and geriatric cognitive disorders
    51. SEMLITSCH HV; SALETU B; ANDERER P; GRUNBERGER J; LINZMAYER L
      TESTING DRUGS FOR IMPAIRED BRAIN-FUNCTION IN OLD-AGE - ON THE EFFECTSOF A SINGLE-DOSE OF BIFEMELANE USING TOPOGRAPHIC MAPPING OF EEG AND EVENT-RELATED POTENTIALS (P300) AND PSYCHOMETRIC MEASUREMENTS IN HEALTHY ELDERLY SUBJECTS

      Human psychopharmacology
    52. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L
      EFFECTS OF THE NOVEL NEUROPROTECTIVE AGENT, RILUZOLE, ON HUMAN BRAIN-FUNCTION AND BEHAVIOR .1. DOUBLE-BLIND, PLACEBO-CONTROLLED EEG MAPPINGAND PSYCHOMETRIC STUDIES UNDER NORMOXIA

      Methods and findings in experimental and clinical pharmacology
    53. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L
      EFFECTS OF THE NOVEL NEUROPROTECTIVE AGENT, RILUZOLE, ON HUMAN BRAIN-FUNCTION AND BEHAVIOR .2. DOUBLE-BLIND, PLACEBO-CONTROLLED EEG MAPPINGAND PSYCHOMETRIC STUDIES UNDER HYPOXIA

      Methods and findings in experimental and clinical pharmacology
    54. SALETU B; BRANDSTATTER N; METKA M; STAMENKOVIC M; ANDERER P; SEMLITSCH HV; HEYTMANEK G; HUBER J; GRUNBERGER J; LINZMAYER L; KURZ C; DECKER K; BINDER G; KNOGLER W; KOLL B
      HORMONAL, SYNDROMAL AND EEG MAPPING STUDIES IN MENOPAUSAL SYNDROME PATIENTS WITH AND WITHOUT DEPRESSION AS COMPARED WITH CONTROLS

      Maturitas
    55. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L; KONIG P
      ON THE CEREBRO-PROTECTIVE EFFECTS OF CAROVERINE, A CALCIUM-CHANNEL BLOCKER AND ANTIGLUTAMATERGIC DRUG - DOUBLE-BLIND, PLACEBO-CONTROLLED, EEG MAPPING AND PSYCHOMETRIC STUDIES UNDER HYPOXIA

      British journal of clinical pharmacology
    56. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L; ZYHLARZ G
      COMPARATIVE PHARMACODYNAMIC STUDIES WITH THE NOVEL SEROTONIN UPTAKE-ENHANCING TIANEPTINE AND - INHIBITING FLUVOXAMINE UTILIZING EEG MAPPINGAND PSYCHOMETRY

      Journal of neural transmission
    57. BIRKHAUSER M; ROZENBAUM H; CHRISTIANSEN C; DELMAS P; GASPARD U; GENNAZZANI A; JAEGER P; METKA M; CASTRO MNE; PALACIOS S; SAMSIOE G; SCHNEIDER HPG; STEVENSON J; ZICHELLA L; AGNUSDEI D; AYALON D; BOULET M; BREART G; BRECKWOLDT M; ALSINA CA; CARDOZO L; GODSLAND I; GORINS A; HESCH RD; HIRVONEN E; HUBER H; HUNTER M; KANIS J; LAATIKAINEN T; LACHOWSKI M; LAURITZEN C; DENOOYER C; PERSSON I; PINES A; RIIS B; RINGE J; ROZENBERG S; SALETU B; SKOUBY J; SPECTOR T; STAMPFER M; STUDD J; STURDEE D; SULLIVAN J; VESSEY M; WHITEHEAD M; WIKLUND I; DEZIEGLER D
      EUROPEAN CONSENSUS DEVELOPMENT CONFERENCE ON MENOPAUSE

      Human reproduction
    58. SALETU B; KLOSCH G; GRUBER G; ANDERER P; UDOMRATN P; FREY R
      FIRST-NIGHT-EFFECTS ON GENERALIZED ANXIETY DISORDER (GAD)-BASED INSOMNIA - LABORATORY VERSUS HOME SLEEP RECORDINGS

      Sleep
    59. DANTENDORFER K; FREY R; MAIERHOFER D; SALETU B
      SUDDEN AROUSALS FROM SLOW-WAVE SLEEP AND PANIC DISORDER - SUCCESSFUL TREATMENT WITH ANTICONVULSANTS - A CASE-REPORT

      Sleep
    60. ANDERER P; SEMLITSCH HV; SALETU B
      MULTICHANNEL AUDITORY EVENT-RELATED BRAIN POTENTIALS - EFFECTS OF NORMAL AGING ON THE SCALP DISTRIBUTION OF N1, P2, N2 AND P300 LATENCIES AND AMPLITUDES

      Electroencephalography and clinical neurophysiology
    61. SEMLITSCH HV; ANDERER P; SALETU B
      COGNITIVE PSYCHOPHYSIOLOGY IN ANXIOLYTIC DRUG RESEARCH

      Biological psychiatry
    62. SALETU B; HITZENBERGER G; GRUNBERGER J; ANDERER P; ZYHLARZ G; LINZMAYER L; RAMEIS H
      DOUBLE-BLIND, PLACEBO-CONTROLLED, PHARMACOKINETIC AND PHARMACODYNAMICSTUDIES WITH 2 NEW FORMULATIONS OF PIRACETAM (INFUSION AND SYRUP) UNDER HYPOXIA IN MAN

      International journal of clinical pharmacology and therapeutics
    63. ZEITLHOFER J; RIEDER A; KAPFHAMMER G; AULL S; BOLITSCHEK J; KUNZE M; SALETU B; LECHNER H
      SLEEP-APNEA AS RISK FACTOR

      Acta medica austriaca
    64. LANGER G; KARAZMAN R; NEUMARK J; SALETU B; SCHONBECK G; GRUNBERGER J; DITTRICH R; PETRICEK W; HOFFMANN P; LINZMAYER L; ANDERER P; STEINBERGER K
      ISOFLURANE NARCOTHERAPY IN DEPRESSIVE PATIENTS REFRACTORY TO CONVENTIONAL ANTIDEPRESSANT DRUG-TREATMENT - A DOUBLE-BLIND COMPARISON WITH ELECTROCONVULSIVE TREATMENT

      Neuropsychobiology
    65. SEMLITSCH HV; ANDERER P; SALETU B; BINDER GA; DECKER KA
      COGNITIVE PSYCHOPHYSIOLOGY IN NOOTROPIC DRUG RESEARCH - EFFECTS OF GINKGO-BILOBA ON EVENT-RELATED POTENTIALS (P300) IN AGE-ASSOCIATED MEMORY IMPAIRMENT

      Pharmacopsychiatry
    66. ANGST J; BORBELY A; ENGEL RR; FERNER U; GASZNER P; HIPPIUS H; LADER M; LINGJAERDE O; RUTHER E; RZWUSKA M; SALETU B; SEDVALL G; SOLDATOS C; STEFANIS CN; STOLL KD
      REPORT ON THE 6TH CONSENSUS CONFERENCE ON THE METHODOLOGY OF CLINICAL-TRIALS WITH HYPNOTIC DRUGS

      Pharmacopsychiatry
    67. ASENBAUM S; ZEITLHOFER J; SALETU B; FREY R; BRUCKE T; PODREKA I; DEECKE L
      TECHNETIUM-99M-HMPAO SPECT IMAGING OF CEREBRAL BLOOD-FLOW DURING REM-SLEEP IN NARCOLEPTICS

      The Journal of nuclear medicine
    68. SCHMEISERRIEDER A; KAPFHAMMER G; BOLITSCHEK J; HOLZINGER B; SKROBAL A; KUNZE M; LECHNER H; SALETU B; ZEITLHOFER J
      SELF-REPORTED PREVALENCE AND TREATMENT OF SLEEP DISORDERS IN AUSTRIA

      Journal of epidemiology and community health
    69. SEMLITSCH HV; ANDERER P; SALETU B
      ACUTE EFFECTS OF THE ANXIOLYTICS SURICLONE AND ALPRAZOLAM ON COGNITIVE INFORMATION-PROCESSING UTILIZING TOPOGRAPHIC MAPPING OF EVENT-RELATED BRAIN POTENTIALS (P300) IN HEALTHY-SUBJECTS

      European Journal of Clinical Pharmacology
    70. GRUNBERGER J; LINZMAYER L; SALETU B; GRUNBERGER M
      A NEW APPROACH TO THE PSYCHOPHARMACOLOGIC AL PUPILLARY OSCILLATIONS HYPOTHESIS AFTER ADMINISTRATION OF A NOOTROPIC COMPOUND

      Arzneimittel-Forschung
    71. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L; KONIG P
      ACUTE CENTRAL EFFECTS OF THE CALCIUM-CHANNEL BLOCKER AND ANTIGLUTAMATERGIC DRUG CAROVERINE - DOUBLE-BLIND, PLACEBO-CONTROLLED, EEG MAPPING AND PSYCHOMETRIC STUDIES AFTER INTRAVENOUS AND ORAL-ADMINISTRATION

      Arzneimittel-Forschung
    72. SALETU B; BRANDSTATTER N; METKA M; STAMENKOVIC M; ANDERER P; SEMLITSCH HV; HEYTMANEK G; HUBER J; GRUNBERGER J; LINZMAYER L; KURZ C; DECKER K; BINDER G; KNOGLER W; KOLL B
      DOUBLE-BLIND, PLACEBO-CONTROLLED, HORMONAL, SYNDROMAL AND EEG MAPPINGSTUDIES WITH TRANSDERMAL ESTRADIOL THERAPY IN MENOPAUSAL DEPRESSION

      Psychopharmacology
    73. SALETU B; PAULUS E; LINZMAYER L; ANDERER P; SEMLITSCH HV; GRUNBERGER J; WICKE L; NEUHOLD A; PODREKA I
      NICERGOLINE IN SENILE DEMENTIA OF ALZHEIMER-TYPE AND MULTI INFARCT DEMENTIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL AND EEG ERP MAPPING STUDY/

      Psychopharmacology
    74. BARBANOJ MJ; ANDERER P; ANTONIJOAN RM; TORRENT J; SALETU B; JANE F
      TOPOGRAPHIC PHARMACO-EEG MAPPING OF INCREASING DOSES OF BUSPIRONE ANDITS COMPARISON WITH DIAZEPAM

      Human psychopharmacology
    75. SALETU B; GRUNBERGER J; LINZMAYER L; SEMLITSCH HV; ANDERER P; CHWATAL K
      PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH A NEW ANXIOLYTIC, SURICLONE, UTILIZING EEG MAPPING AND PSYCHOMETRY

      British journal of clinical pharmacology
    76. SALETU B; KUFFERLE B; GRUNBERGER J; FOLDES P; TOPITZ A; ANDERER P
      CLINICAL, EEG MAPPING AND PSYCHOMETRIC STUDIES IN NEGATIVE SCHIZOPHRENIA - COMPARATIVE TRIALS WITH AMISULPRIDE AND FLUPHENAZINE

      Neuropsychobiology
    77. SALETU B; ANDERER P; BRANDSTATTER N; FREY R; GRUNBERGER J; KLOSCH G; MANDL M; WETTER T; ZEITLHOFER J
      INSOMNIA IN GENERALIZED ANXIETY DISORDER - POLYSOMNOGRAPHIC, PSYCHOMETRIC AND CLINICAL INVESTIGATIONS BEFORE, DURING AND AFTER THERAPY WITHA LONG-HALF-LIFE VERSUS A SHORT-HALF-LIFE BENZODIAZEPINE (QUAZEPAM VERSUS TRIAZOLAM)

      Neuropsychobiology
    78. SALETU B; SCHULZ H; HERRMANN WM; ANDERER P; SHROTRIYA RC; VANBRABANT E
      BMS-181168 FOR PROTECTION OF THE HUMAN BRAIN AGAINST HYPOXIA - DOUBLE-BLIND, PLACEBO-CONTROLLED EEG MAPPING STUDIES

      Pharmacopsychiatry
    79. MOLLER HJ; MAURER I; SALETU B
      PLACEBO-CONTROLLED TRIAL OF THE XANTHINE DERIVATIVE PROPENTOFYLLINE IN DEMENTIA

      Pharmacopsychiatry
    80. ANGST J; BECH P; BRUINVELS J; ENGEL RR; FERNER U; GUELFI JD; LINGJAERDE O; MULLEROERLINGHAUSEN B; DESOUSA MP; PAYKEL E; RIMON R; RZEWUSKA M; SALETU B; SPIEGEL R; STASSEN HH; STOLL KD; WIESEL FA; WOGGON B; ZVOLSKY P
      REPORT ON THE 5TH CONSENSUS CONFERENCE - METHODOLOGY OF LONG-TERM CLINICAL-TRIALS IN PSYCHIATRY

      Pharmacopsychiatry
    81. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L; PAKESCH G; ZYHLARZ G
      EFFECT-KINETICS ON BRAIN PROTECTION OF 2 CODERGOCRINE-MESYLATE PREPARATIONS (ARAMEXE-RETARD(R) AND HYDERGINE(R)) BY EEG MAPPING AND PSYCHOMETRY UNDER HYPOXIA

      Archives of gerontology and geriatrics
    82. GRUNBERGER J; LINZMAYER L; GRUNBERGER M; SALETU B
      A NEW TECHNIQUE FOR MEASUREMENT OF CENTRA L NERVOUS ACTIVATION - FOURIER-ANALYSIS OF PUPILLARY OSCILLATIONS IN DEPRESSED-PATIENTS

      Wiener Klinische Wochenschrift
    83. ZEITLHOFER J; RIEDER A; KAPFHAMMER G; BOLITSCHEK J; SKROBAL A; HOLZINGER B; LECHNER H; SALETU B; KUNZE M
      EPIDEMIOLOGY OF SLEEP DISTURBANCES IN AUS TRIA

      Wiener Klinische Wochenschrift
    84. ANDERER P; SALETU B; KLOPPEL B; SEMLITSCH HV; WERNER H
      DISCRIMINATION BETWEEN DEMENTED PATIENTS AND NORMALS BASED ON TOPOGRAPHIC EEG SLOW-WAVE ACTIVITY - COMPARISON BETWEEN Z-STATISTICS, DISCRIMINANT-ANALYSIS AND ARTIFICIAL NEURAL-NETWORK CLASSIFIERS

      Electroencephalography and clinical neurophysiology
    85. SCHIMICEK P; ZEITLHOFER J; ANDERER P; SALETU B
      AUTOMATIC SLEEP-SPINDLE DETECTION PROCEDURE - ASPECTS OF RELIABILITY AND VALIDITY

      Clinical EEG electroencephalography
    86. SALETU B; BRANDSTATTER N; ANDERER P; SEMLITSCH HV; BINDER G; DECKER K; METKA M; HUBER J; KNOGLER W
      NEUROPHYSIOLOGICAL INVESTIGATIONS IN MENOPAUSAL SYNDROME WITH AND WITHOUT DEPRESSION AND NORMAL CONTROLS - EEG AND EP MAPPING

      Neuropsychopharmacology
    87. BRANDSTATTER N; SALETU B; METKA M; GRUNBERGER J; LINZMAYER L; ANDERER P; STAMENKOVIC M; RESINGER E; HUBER J; KNOGLER W; ZYHLARZ G; PFERSMANN D
      CLINICAL, PSYCHOPATHOLOGICAL AND PSYCHOMETRIC STUDIES IN MENOPAUSAL SYNDROME PATIENTS WITH AND WITHOUT DEPRESSION AS COMPARED WITH NORMAL CONTROLS

      Neuropsychopharmacology
    88. SALETU B; BARBANOJ MJ; ANDERER P; SIEGHART W; GRUNBERGER J
      CLINICAL-PHARMACOLOGICAL STUDY WITH THE 2 ISOMERS (D-FENFLURAMINE, L-FENFLURAMINE) OF FENFLURAMINE AND ITS COMPARISON WITH CHLORPROMAZINE AND D-AMPHETAMINE - BLOOD-LEVELS, EEG MAPPING AND SAFETY EVALUATION

      Methods and findings in experimental and clinical pharmacology
    89. GRUNBERGER J; SALETU B; LINZMAYER L; BARBANOJ MJ
      CLINICAL-PHARMACOLOGICAL STUDY WITH THE 2 ISOMERS (D-FENFLURAMINE, L-FENFLURAMINE) OF FENFLURAMINE AND ITS COMPARISON WITH CHLORPROMAZINE AND D-AMPHETAMINE - PSYCHOMETRIC AND PSYCHOPHYSIOLOGICAL EVALUATION

      Methods and findings in experimental and clinical pharmacology
    90. ANDERER P; BARBANOJ MJ; SALETU B; SEMLITSCH HV
      RESTRICTION TO A LIMITED SET OF EEG-TARGET VARIABLES MAY LEAD TO MISINTERPRETATION OF PHARMACO-EEG RESULTS

      Neuropsychobiology
    91. SALETU B; SALETU M; GRUNBERGER J; FREY R; ANDERER P; MADER R
      TREATMENT OF THE ALCOHOLIC ORGANIC BRAIN-SYNDROME - DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL, PSYCHOMETRIC AND ELECTROENCEPHALOGRAPHIC MAPPING STUDIES WITH MODAFINIL

      Neuropsychobiology
    92. SEMLITSCH HV; ANDERER P; SALETU B; BINDER GA; DECKER KA
      ACUTE EFFECTS OF THE NOVEL ANTIDEPRESSANT VENLAFAXINE ON COGNITIVE EVENT-RELATED POTENTIALS (P300), EYE BLINK RATE AND MOOD IN YOUNG HEALTHY-SUBJECTS

      International clinical psychopharmacology
    93. GRUNBERGER J; LINZMAYER L; DIETZEL M; SALETU B
      THE EFFECT OF BIOLOGICALLY-ACTIVE LIGHT ON THE NOOPSYCHE AND THYMOPSYCHE AND ON PSYCHOPHYSIOLOGICAL VARIABLES IN HEALTHY-VOLUNTEERS

      International journal of psychophysiology
    94. BAUMGARTNER A; DIETZEL M; SALETU B; WOLF R; CAMPOSBARROS A; GRAF KJ; KURTEN I; MANNSMANN U
      INFLUENCE OF PARTIAL SLEEP-DEPRIVATION ON THE SECRETION OF THYROTROPIN, THYROID-HORMONES, GROWTH-HORMONE, PROLACTIN, LUTEINIZING-HORMONE, FOLLICLE-STIMULATING-HORMONE, AND ESTRADIOL IN HEALTHY-YOUNG WOMEN

      Psychiatry research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 04:17:29